We examined the immunofluorescence and ultrastructural changes of insulin-producing B cells in the center and at the periphery of islets of Langerhans during in vivo stimulation by glucose and glibenclamide. A decreased insulin immunostaining was detected in islets from the splenic rat pancreas after 1.5 h of glucose stimulation. By contrast, immunofluorescence changes became apparent in islets from the duodenal pancreas only after greater than 3 h of hyperglycemia. In both cases, the immunolabeling of central B cells decreased before that of peripheral B cells. Similar changes were seen following in vivo stimulation of insulin secretion by glibenclamide. At the ultrastructural level, hyperglycemia decreased the volume density of B cell secretory granules and increased that of rough endoplasmic reticulum and Golgi apparatus. These changes were also detected earlier in central than in peripheral B cells and earlier in splenic than in duodenal islets. The data show that B cells form a heterogeneous population in vivo. 
Introduction
Studies on the insulin-producing B cells of the islets of Langerhans are usually performed with the implicit assumption that these cells are all alike and secrete synchronously and homogeneously under most conditions. There is, however, evidence that B cells may be structurally and functionally different. Thus, within an islet, neighboring B cells show variable amounts of secretory granules and rough endoplasmic reticulum (1) and different thresholds for glucose-induced electrical activity (2, 3) . The findings of regional differences of B cells with regard to nucleus size (4, 5) , incorporation of [3H]thymidine (6) , number of gap junctions (7) , extent of dye coupling (8) , and electrical activity (9, 10) further suggest that B cells may be affected by the different cellular and hormonal environment they are facing in the center and at the periphery of the islets (1 1). However, whether these differences reflect an actual functional heterogeneity of B cells in terms of their ability to respond to insulin secretagogues remains to be established.
We have recently reported that individual B cells, exposed simultaneously to the same environment, differ in the rate at which they secrete insulin (12) and thus form a heterogeneous population in vitro. This study was undertaken to assess whether B cells are also functionally heterogeneous in vivo. Furthermore, we wished to determine whether any observed heterogeneity could be related to regional differences of B cell environment, within individual islets from either the duodenal or the splenic portion of the pancreas (13) .
Methods

Glucose infusion
Experimental procedure. Male Sprague-Dawley (SIVZ) rats, weighing 300-350 g, were implanted with a catheter into the jugular vein. The catheter was passed subcutaneously to emerge at the top ofthe head and was attached on the skull using stainless steel screws and dental resin (14) . Thereafter, the implanted catheter was rinsed daily with saline containing 500 IU heparin/ml and 40% polyvinylpyrrolidone. The rats were infused 1 wk after surgery, once they had regained the control weight curve. Infusion was started by a bolus injection, via the implanted catheter, of 350 mg* Kg' D-glucose (given as a 40% solution) and continued, up to the end of the experiment, by connecting the catheter to an infusion pump delivering 180 mg * Kg-' * minI glucose (given as a 20% solution).
Controls received similar volumes of saline. Throughout the experiment, all rats had free access to water and food and could move freely within their cage. Before starting the infusion and periodically throughout it, blood samples were taken at the tail of each rat for measurement of plasma glucose and insulin, by the glucose oxidase method and a radioimmunoassay with a charcoal separation step, respectively.
Islets of Langerhans were isolated from the pancreas of 8 control and 12 glucose-infused rats after 1.5, 3, 12, and 24 h of infusion, using collagenase digestion (15) and purification on Ficoll gradients (16) . In each animal, the lower third of the pancreas head was dissected separately from the rest ofthe gland and the two portions were processed in parallel to isolate "duodenal" and "splenic" islets, respectively (13) . Both islet types were isolated and collected in 50-60 min and then immediately fixed in a 2.5% glutaraldehyde solution in 0.1 M phosphate buffer. Subsequently, the islets were postfixed in 1% osmium tetroxyde and processed for conventional electron microscopy according to standard procedures. The duodenal and splenic pancreas of six other rats (one control and five glucose-infused) were fixed in Bouin's solution at the end of the infusion and processed for light microscopy according to standard procedures.
electron microscope (Philips Electronic Instruments, Inc., Mahwah, NJ). B cells were analyzed morphometrically in the center and at the periphery of each islet, the limit between the two zones being determined by the position of islet sections with respect to the bars of the supporting grid (7) . In the peripheral islet region, B cells were considered "peripheral" if they were seen to contact at least one non-B cell (Figs. 2 A and 3 A) . In the central islet region, B cells were considered "central" whenever they were surrounded only by other B cells (Figs. 2 B and 3 B) .
A total of -100 and 600 B cells were scored per animal and per group, respectively. This sample gave cumulative standard errors representing < 5-10% ofthe mean estimate ofeach parameter and thus was considered representative of the native B cell population ( 18) .
B cell organelles were identified on electron micrographs according to standard criteria (1) . Single membrane-bound profiles were attributed to beta-secretory granules whenever they showed a pale or dark core. Thus, no distinction was made between the granules with a tightly fitting core and those with a clear halo, nor between coated and uncoated granules. Golgi apparatus was evaluated by outlining the area occupied by the stacks of cisternae and their related vesicles. Rough endoplasmic reticulum (RER)' was evaluated as the area encompassing flattened cisternae and vesicles bearing ribosomes, together with the little cytoplasm between them.
For the evaluation of nuclear-to-cytoplasm ratio, one photograph per cell was taken at the original magnification of 2,OOOX. For the evaluation of RER, Golgi apparatus, and secretory granule volumes, two opposite regions of each B cell were photographed at the original magnification of8,600X. For all compartments, point counting was performed on negatives enlarged 4.5 times by projection on a screen fitted with a coherent double quadratic lattice test system (lattice point ratio, 99:981) and volume density was calculated according to formula 4.1 ofreference 18. Volume density values were normally distributed for all organelles and thus were expressed as mean±SEM and compared using an unpaired Student's t test.
Glibenclamide treatment
Experimental procedure. Rats were either injected once i.p. with 2 mg Kg-I glibenclamide (7, 19) and sacrificed 2, 6, and 12 h later, or received two injections ofthe drug with a 12-h interval and were sacrificed 24 h after the beginning of the treatment. Noninjected rats served as control. The effects ofeach treatment were followed by measuring glucose and insulin plasma levels and insulin content of pancreatic fragments, as described above. At the end of each treatment, the duodenal and the splenic portion of each pancreas were dissected separately (13) 
Results
Glucose stimulation. At the beginning of the experiment, plasma glucose (128±3 mg%) and insulin (4.5±0.4 ng/ml) were similar in all rats (n = 2-3 in each group). Glycemia remained unchanged throughout the saline infusion of controls. By contrast, it increased rapidly in the rats infused with glucose. Thus, after 15 min of this infusion, glycemia was elevated (P < 0.001) 2.2-2.6-fold over control value and remained at least at that level up to the end of the experiment. At sacrifice, blood glucose was 249±8 mg%, 319±51 mg%, 400±38 mg%, and 482±28 mg% in the rats infused with glucose for 1.5, 3, 12 , and 24 h, respectively.
Plasma insulin was also markedly increased during glucose infusion. At the end of the experiment, insulinemia was 20.2±8.7 ng/ml, 26.2±15.0 ng/ml, 38.3±4.7 ng/ml, and 18.3±1.1 ng/ml in the rats infused with glucose for 1.5, 3, 12, and 24 h, respectively. These values represented a 5-15-fold increase (P < 0.001) over control levels.
After immunostaining of pancreas for insulin, fluorescent B cells were homogeneously distributed throughout the large (diameter, > 200 ,um) islets of normoglycemic rats ( Fig. 1 F) . By contrast, in glucose-infused rats, fluorescent B cells rapidly became less abundant in the center of these microorgans (Fig. 1, A-D). Up to the 12th hour of infusion, this change was more evident in splenic ( Fig. 1 (Fig. 1 E) . At this time, however, the sparce extrainsular B cells and the non-B cells of the outermost islet layers were still clearly immunolabeled by their respective specific antisera (not shown).
At the electron microscope level, the cytoplasmic organization of B cells of normoglycemic rats (all animals at the beginning of the experiment and throughout saline infusion) corresponded to that described in noninfused controls (1) Immunostaining of pancreatic sections for insulin after various periods of glucose infusion (A-F) or glibenclamide treatment (G and H). In controls, the immunofluorescent B cells were evenly distributed throughout the islets (F). After 3 h of glucose infusion (A and B), the labeling was unchanged at the periphery of the islets but decreased in the center of the microorgans. This regional difference was more apparent in splenic (B) than in duodenal islets (A) and became more accentuated with time. After 6 (C) and 12 h of infusion (D), the few B cells still immunostainable in splenic islets were mostly located at their periphery. After .9to ulation (Fig. 2 B) , whereas it became obvious in peripheral Bcells only after 12 h of stimulation (Fig. 3 A) . The difference between central and peripheral B cells was no longer detectable after 24 h of glucose infusion, when most B-cells were degranulated throughout the islets (Fig. 3, A (Fig. 4) . This change was associated with a parallel increase (P < 0.001) in the volume density of RER (Fig. 4) . The volume density of the Golgi apparatus compartment also increased during glucose stimulation, reaching statistical significance (P < 0.001) after 3 h of infusion (Fig. 4) . Regression analysis revealed a significant (P < 0.002) inverse linear correlation between the relative volumes of granules and of either RER (r = -0.99) or Golgi (r = -0.98) compartments.
Comparison ofthe data from peripheral B cells did not reveal differences between splenic and duodenal islets, under both control and glucose-stimulated conditions (not shown). By contrast, central B cells showed a lower (P < 0.001) volume density of secretory granules in splenic than in duodenal islets (Fig. 5) . This difference increased (P < 0.001) during the first 3 h of stimulation ( Fig. 5 ) but was no more apparent after 12 and 24 h of glucose challenge.
In both splenic and duodenal islets, the glucose-induced changes were detected much earlier in central than in peripheral B cells. As seen in Fig. 6 , which summarizes the data for the entire islet population, the volume density of secretory granules was already decreased (P < 0.001) in central B cells after 1.5 h ofglucose stimulation, whereas in peripheral B cells, it changed only from the third hour ofglucose infusion onward. Similarly, the volume density of RER and of Golgi apparatus increased first in central B cells and later in peripheral B cells (Fig. 6) .
Glibenclamide stimulation. Glibenclamide decreased transitorily plasma glucose to 47 and 67% of control value (109±8 mg%) after the first 2 and 6 h oftreatment, respectively. Glycemia returned then to control level until the end of the experiment. At that time, the plasma insulin level (5.3±0.7 ng/ml) was similar to that ofcontrols. By contrast, the insulin content ofboth splenic and duodenal fragments was rapidly decreased (P < 0.001) by the After immunostaining for insulin, B cells of control pancreas were intensely fluorescent in the center and at the periphery of both duodenal and splenic islets. 2 h after the first glibenclamide injection, B cell fluorescence appeared unchanged in duodenal islets whereas it was noticeably decreased in the center ofsplenic islets (not shown). The difference between central and peripheral B cells and between duodenal (Fig. 1 G) and splenic islets (Fig.  1 H) increased with time. One day after the onset oftreatment, the few B cells that were still immunostainable were more numerous in duodenal than in splenic islets and, within the latter microorgans, predominated in the peripheral layers (not shown).
Quantitative evaluation showed that the volume density of immunostained B cells, which reflects mostly their content in secretory granules, was similar throughout splenic and duodenal control islets (Fig. 7) . During glibenclamide stimulation, the volume density offluorescent B cells decreased faster (P < 0.001) in splenic than in duodenal islets (Fig. 7) . Whereas in splenic islets this decrease was larger (P < 0.001) for central than for peripheral B cells, such a difference was not observed in duodenal islets (Fig. 7) .
Discussion
We have shown that, upon in vivo stimulation by either glucose or glibenclamide, the main organelles involved in the biosynthesis, processing, storage, and release ofinsulin undergo changes at different rates, depending on the location of B cells within the islets and on the location of the islets within the pancreas. These observations indicate that B cells show a regional heterogeneity in vivo in terms oftheir ability to respond to stimulation by insulin secretagogues.
The morphometric parameters considered to reflect the response ofB cells to stimulation were the volume density ofbetasecretory granules, RER, and Golgi apparatus as well as that of B cells immunolabeled with an antiinsulin serum. These parameters changed during the sustained stimulation of insulin secretion induced by glucose and glibenclamide. Thus, the relative volume of secretory granules decreased with time whereas that of RER and Golgi apparatus increased, in a way consistent with the secretagogue-induced stimulation ofgranule exocytosis (19) (20) (21) and islet protein biosynthesis (22) (23) (24) , respectively. There is also evidence that splenic islets have higher rates of stimulated insulin secretion and biosynthesis than duodenal islets (25) (26) (27) . Accordingly, morphometric analysis detected changes of B cell organelles first in splenic and then in duodenal islets, therefore extending to in vivo situations the in vitro findings that islet heterogeneity is, at least in part, related to the differential distribution of the microorgans within the pancreas.
Nevertheless, the unique advantage of morphometry was to further reveal the heterogeneity of B cells located in different The physiological implications of the different time course and rate of insulin secretion from central and peripheral B cells remain also to be established. The observation that insulin is secreted in a nonrandom fashion from at least two compartments has suggested the existence of subpopulations of either betasecretory granules or B cells, differing in their sensitivity to secretagogues (36) (37) (38) (39) . At this stage, we have provided evidence that subpopulations ofB cells that differ in their ability to respond to physiological and pharmacological insulin secretagogues indeed exist in distinct, recognizable regions of the islets of Langerhans.
